Alzheimer’s disease medication use and adherence patterns by race and ethnicity
dc.contributor.author | Olchanski, Natalia | |
dc.contributor.author | Daly, Allan T. | |
dc.contributor.author | Zhu, Yingying | |
dc.contributor.author | Breslau, Rachel | |
dc.contributor.author | Cohen, Joshua T. | |
dc.contributor.author | Neumann, Peter J. | |
dc.contributor.author | Faul, Jessica D. | |
dc.contributor.author | Fillit, Howard M. | |
dc.contributor.author | Freund, Karen M. | |
dc.contributor.author | Lin, Pei-Jung | |
dc.date.accessioned | 2023-05-01T19:09:41Z | |
dc.date.available | 2024-05-01 15:09:39 | en |
dc.date.available | 2023-05-01T19:09:41Z | |
dc.date.issued | 2023-04 | |
dc.identifier.citation | Olchanski, Natalia; Daly, Allan T.; Zhu, Yingying; Breslau, Rachel; Cohen, Joshua T.; Neumann, Peter J.; Faul, Jessica D.; Fillit, Howard M.; Freund, Karen M.; Lin, Pei-Jung (2023). "Alzheimer’s disease medication use and adherence patterns by race and ethnicity." Alzheimer’s & Dementia 19(4): 1184-1193. | |
dc.identifier.issn | 1552-5260 | |
dc.identifier.issn | 1552-5279 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176247 | |
dc.description.abstract | BackgroundWe examined racial and ethnic differences in medication use for a representative US population of patients with Alzheimer’s disease and related dementias (ADRD).MethodsWe examined cholinesterase inhibitors and memantine initiation, non-adherence, and discontinuation by race and ethnicity, using data from the 2000–2016 Health and Retirement Study linked with Medicare and Medicaid claims.ResultsAmong newly diagnosed ADRD patients (n = 1299), 26% filled an ADRD prescription ≤90 days and 36% ≤365 days after diagnosis. Among individuals initiating ADRD-targeted treatment (n = 1343), 44% were non-adherent and 24% discontinued the medication during the year after treatment initiation. Non-Hispanic Blacks were more likely than Whites to not adhere to ADRD medication therapy (odds ratio: 1.50 [95% confidence interval: 1.07–2.09]).DiscussionInitiation of ADRD-targeted medications did not vary by ethnoracial group, but non-Hispanic Blacks had lower adherence than Whites. ADRD medication non-adherence and discontinuation were substantial and may relate to cost and access to care.HIGHLIGHTSInitiation of anti-dementia medications among newly diagnosed Alzheimer’s disease and related dementias (ADRD) patients was low in all ethnoracial groups.ADRD medication non-adherence and discontinuation were substantial and may relate to cost and access to care.Compared to Whites, Blacks and Hispanics had lower use, poorer treatment adherence, and more frequent discontinuation of ADRD medication, but when controlling for disease severity and socioeconomic factors, racial disparities diminish.Our findings demonstrate the importance of adjusting for socioeconomic characteristics and disease severity when studying medication use and adherence in ADRD patients. | |
dc.publisher | National Academy Press | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | health disparities | |
dc.subject.other | acetylcholinesterase inhibitors | |
dc.subject.other | Alzheimer’s disease | |
dc.subject.other | anti-dementia medication | |
dc.subject.other | cognitive health | |
dc.subject.other | dementia | |
dc.title | Alzheimer’s disease medication use and adherence patterns by race and ethnicity | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurology and Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176247/1/alz12753-sup-0001-COIdisclosure.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176247/2/alz12753.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176247/3/alz12753_am.pdf | |
dc.identifier.doi | 10.1002/alz.12753 | |
dc.identifier.source | Alzheimer’s & Dementia | |
dc.identifier.citedreference | McCammon R, Fisher GG, Hassan H, Faul JD, Rogers W, Weir DR. Health and retirement study imputation of cognitive functioning measures: 1992-2016. HRS User Guide. 2019. https://hrs.isr.umich.edu/publications/biblio/5760 | |
dc.identifier.citedreference | U. S. Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement. JAMA. 2020; 323 ( 8 ): 757 - 763. doi: 10.1001/jama.2020.0435 | |
dc.identifier.citedreference | Qaseem A, Snow V. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008; 148 ( 5 ): 370 - 378. doi: 10.7326/0003-4819-148-5-200803040-00008 | |
dc.identifier.citedreference | Barthold D, Joyce G, Ferido P, et al. Pharmaceutical treatment for Alzheimer’s disease and related dementias: utilization and disparities. J Alzheimers Dis. 2020; 76 ( 2 ): 579 - 589. doi: 10.3233/JAD-200133 | |
dc.identifier.citedreference | Mehta KM, Yin M, Resendez C, Yaffe K. Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease. Neurology. 2005; 65 ( 1 ): 159 - 162. doi: 10.1212/01.wnl.0000167545.38161.48 | |
dc.identifier.citedreference | Zuckerman IH, Ryder PT, Simoni-Wastila L, et al. Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries. J Gerontol B Psychol Sci Soc Sci. 2008; 63 ( 5 ): S328 - 333. | |
dc.identifier.citedreference | Thorpe CT, Fowler NR, Harrigan K, et al. Racial and ethnic differences in initiation and discontinuation of antidementia drugs by Medicare beneficiaries. J Am Geriatr Soc. 2016; 64 ( 9 ): 1806 - 1814. doi: 10.1111/jgs.14403 | |
dc.identifier.citedreference | Jones ME, Petersen I, Walters K, et al. Differences in psychotropic drug prescribing between ethnic groups of people with dementia in the United Kingdom. Clin Epidemiol. 2020; 12: 61 - 71. doi: 10.2147/CLEP.S222126 | |
dc.identifier.citedreference | Murchison CF, Kennedy RE, McConathy JE, Roberson ED. Racial differences in Alzheimer’s disease specialist encounters are associated with usage of molecular imaging and dementia medications: an enterprise-wide analysis using i2b2. J Alzheimers Dis. 2021; 79 ( 2 ): 543 - 557. doi: 10.3233/JAD-200796 | |
dc.identifier.citedreference | Campbell NL, Perkins AJ, Gao S, et al. Adherence and tolerability of Alzheimer’s disease medications: a pragmatic randomized trial. J Am Geriatr Soc. 2017; 65 ( 7 ): 1497 - 1504. doi: 10.1111/jgs.14827 | |
dc.identifier.citedreference | Chin AL, Negash S, Hamilton R. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011; 25 ( 3 ): 187 - 195. doi: 10.1097/WAD.0b013e318211c6c9 | |
dc.identifier.citedreference | Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ. Pharmacological treatment of Alzheimer’s disease: effect of race and demographic variables. J Alzheimers Dis. 2010; 19 ( 2 ): 665 - 672. doi: 10.3233/jad-2010-1269 | |
dc.identifier.citedreference | The Health and Retirement Study: Aging in the 21st Century Challeneges and Opportunities for Americans. 2017. https://hrsonline.isr.umich.edu/sitedocs/databook/inc/pdf/HRS-Aging-in-the-21St-Century.pdf?_ga=2.56229230.479190759.1630602349-918756628.1630602349&_ga=2.56229230.479190759.1630602349-918756628.1630602349 | |
dc.identifier.citedreference | CCW Chronic Conditions Algorithms: Alzheimer’s Disease and Related Disorders or Senile Dementia. HealthAPT. Accessed 2020. https://www2.ccwdata.org/documents/10280/19139608/ccw-cond-algo-alzdisorders.pdf | |
dc.identifier.citedreference | Drabo EF, Barthold D, Joyce G, Ferido P, Chang Chui H, Zissimopoulos J. Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries. Alzheimers Dement. 2019; 15 ( 11 ): 1402 - 1411. doi: 10.1016/j.jalz.2019.07.005 | |
dc.identifier.citedreference | Xiong S, Wu J, Li M, Lu K. Association between satisfaction with quality of care and ANTI-Dementia medication adherence among elderly adults with Alzheimer’s disease and related dementias. Value Health. 2021; 24: S93 - S93. | |
dc.identifier.citedreference | Bent-Ennakhil N, Coste F, Xie L, et al. A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer’s disease patients. Neurol Ther. 2017; 6 ( 1 ): 131 - 144. doi: 10.1007/s40120-017-0067-7 | |
dc.identifier.citedreference | Koller D, Hua T, Bynum JP. Treatment patterns with antidementia drugs in the United States: Medicare cohort study. J Am Geriatr Soc. 2016; 64 ( 8 ): 1540 - 1548. doi: 10.1111/jgs.14226 | |
dc.identifier.citedreference | Lin PJ, Daly AT, Olchanski N, et al. Dementia diagnosis disparities by race and ethnicity. Med Care. 2021; 59 ( 8 ): 679 - 686. doi: 10.1097/MLR.0000000000001577 | |
dc.identifier.citedreference | Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academy Press. 2002. | |
dc.identifier.citedreference | Ayalon L. Re-examining ethnic differences in concerns, knowledge, and beliefs about Alzheimer’s disease: results from a national sample. Int J Geriatr Psychiatry. 2013; 28 ( 12 ): 1288 - 1295. doi: 10.1002/gps.3959 | |
dc.identifier.citedreference | Epps F, Rose KM, Lopez RP. Who’s your family?: African American caregivers of older adults with Dementia. Res Gerontol Nurs. 2019; 12 ( 1 ): 20 - 26. doi: 10.3928/19404921-20181212-04 | |
dc.identifier.citedreference | Kosloski K, Schaefer JP, Allwardt D, Montgomery RJ, Karner TX. The role of cultural factors on clients’ attitudes toward caregiving, perceptions of service delivery, and service utilization. Home Health Care Serv Q. 2002; 21 ( 3-4 ): 65 - 88. doi: 10.1300/J027v21n03_04 | |
dc.identifier.citedreference | Martinez IL, Acosta Gonzalez E, Quintero C, Vania MJ. The experience of Alzheimer’s disease family caregivers in a Latino community: expectations and incongruences in support services. J Gerontol B Psychol Sci Soc Sci. 2022; 77 ( 6 ): 1083 - 1093. doi: 10.1093/geronb/gbab170 | |
dc.identifier.citedreference | Park S, White L, Fishman P, Larson EB, Coe NB. Health care utilization, care satisfaction, and health status for Medicare advantage and traditional medicare beneficiaries with and without Alzheimer disease and related Dementias. JAMA Netw Open. 2020; 3 ( 3 ): e201809. doi: 10.1001/jamanetworkopen.2020.1809 | |
dc.identifier.citedreference | The Henry J. Kaiser Family Foundation. Profile of Medicare Beneficiaries by Race and Ethnicity: a Chartpack. 2016. https://files.kff.org/attachment/chartpack-profile-of-medicare-beneficiaries-by-race-and-ethnicity-a-chartpack | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.